Analyst downgrades: ABT, BCS, SNDK, MSW and TXN
Posted Oct 11th 2007 11:10AM by Eric Buscemi
Filed under: Analyst reports, Analyst upgrades and downgrades, Abbott Laboratories (ABT), Texas Instruments (TXN), Barclays plc ADS (BCS), SanDisk Corp (SNDK), Burlington Northern Santa Fe (BNI)
.gif)
MOST NOTEWORTHY: Abbott Labs, Barclays, SanDisk, Mission West Properties and Texas Instruments were today's noteworthy downgrades:
- Wachovia downgraded shares of Abbott Labs (NYSE: ABT) to Market Perform from Outperform reflect several challenges to the company's key franchises. In particular, Wachovia cites the potential delay of the drug-eluting stent Xience launch in the U.S. and decelerating growth of Humira.
- ABN Amro downgraded shares of Barclays (NYSE: BCS) to Hold from Buy to reflect the capital markets, lower UK bank non-interest income and higher bad debts.
- Oppenheimer downgraded shares of SanDisk Corporation (NASDAQ: SNDK) to Neutral from Buy as they expect many of the advantages that drove shares to unwind in Q4 and into 1H08.
- Mission West Properties (NYSE: MSW) was downgraded to Hold from Buy at Stifel, as they now believe the possibility of a sale is 50%/50% and could be pushed back to 1H08.
- Think Equity downgraded shares of Texas Instruments (NYSE: TXN) to Source of Funds from Accumulate as they believe competition could hinder Q4 and 2008 growth for wireless.
OTHER DOWNGRADES:
Tags: abbott, abt, analyst, barclays, bcs, bni, burlington northern santa fe, BurlingtonNorthernSantaFe, csx, downgrade, mission west, MissionWest, molson coors, MolsonCoors, msw, nasdaq, ndaq, sandisk, sndk, tap, texas instruments, TexasInstruments, txn, valueclick, vclk, xrtx, xyratex
Cramer on BloggingStocks: Don't paint everything with the jobs brush
Seven banks go up in smoke ahead of the holiday weekend
Sears offering hedge for consumers who lose their job -- good idea?
